The metabolic variables and pathological examination demonstrated that Leprdb/db mice significantly enhanced body weight (approximately 1.8-fold vs. Leprdb/m mice), elevated glucose, insulin, and triacylglycerol, and exacerbated retinopathy and nephropathy compared with Leprdb/m mice. The gene discussed is INS; the disease is kidney disorder.